
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
At Intellipharmaceutics, we are engaged in the research, development and commercialization of pharmaceutical products, both novel and generic, with a particular emphasis in the controlled-release & opioid abuse deterrence space. Intellipharmaceutics also operates a contract analytical services lab in Toronto that provides Methods Development, Validation & Transfer, Quality Control Testing, Stability Testing and Category 1 Abuse Deterrent Studies. Intellipharmaceutics International is currently trading on the OTCQB and TSX (OTCQB: IPCIF; TSX: IPCI)
Generic pharmaceuticals,controlled-release drug delivery,hypermatrix (tm) technology,abuse deterrent,analytical testing,quality control testing,category 1 abuse deterrent sutdies,abuse deterrent formulations,contract analytical servics,and stability studies
Intellipharmaceutics international operates in the Pharmaceutical manufacturing industry.
Intellipharmaceutics international's revenue is < 1m
Intellipharmaceutics international has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.